Vertiv (VRT)

NYSEIndustrialsElectrical Equipment & PartsSnapshot 2026-10-15

$206.42-3.88%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Vertiv’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.4%

+10% or more+5%0%−5%−10% or less

9.14 → 9.18 EPS · FY ending Dec 31, 2027 · 16 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 16 to 16; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Deliver diluted EPS of $5.60 to $5.70 in 2026	A primary condition in Vertiv's published investment case. The stated target is >= $5.60.	Broken	EPS falls below $5.60 in FY26	Diluted EPS: $1.27 per share FY2026-Q2; GAAP. Published target: >= $5.60. Target period is not explicitly aligned with this observation. Source published Jul 29, 20261.27 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 3548dfc9-8d23-40ea-ad05-0c455eb3d463. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve revenue of $13.5 to $14 billion in 2026	A primary condition in Vertiv's published investment case. The stated target is >= $13.5 billion.	Broken	Revenue falls below $13.5 billion in FY26	Revenue: $3.274B FY2026-Q2; GAAP. Published target: >= $13.5 billion. Target period is not explicitly aligned with this observation. Source published Jul 29, 20263,274,300,000 USD · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 3548dfc9-8d23-40ea-ad05-0c455eb3d463. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Complete and integrate Strategic Thermal Labs acquisition	A supporting condition in Vertiv's published investment case. The stated target is Acquisition closed and integrated by end 2026.	Intact	Acquisition not completed or integration fails by end 2026	Acquisition closed by end 2026 target met ThermoKey closed June 2026; King Environmental deal announced Sept 2026 with Q4 2026 close expected. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$9.18

$8.82 → $9.18 · observed estimates

FY2027 revenue$18.22B

$17.80B → $18.22B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$8.82	$17,803,202,853	14 / 20
2026-07-25	$8.83	$17,869,199,440	28 / 28
2026-07-26	$8.82	$17,803,202,853	14 / 20
2026-07-27	$8.82	$17,803,193,222	15 / 21
2026-07-28	$8.83	$17,869,199,440	28 / 28
2026-07-29	$8.82	$17,803,931,153	16 / 21
2026-07-30	$8.83	$17,869,963,730	28 / 28
2026-07-31	$8.99	$17,994,228,236	16 / 21
2026-08-01	$8.99	$17,994,228,236	16 / 21
2026-08-02	$9.09	$18,100,631,374	16 / 21
2026-08-03	$9.06	$18,109,846,680	28 / 28
2026-08-04	$9.06	$18,109,846,680	28 / 28
2026-08-05	$9.09	$18,100,631,374	16 / 21
2026-08-06	$9.09	$18,100,631,374	16 / 21
2026-08-08	$9.11	$18,136,435,272	16 / 21
2026-08-09	$9.10	$18,141,217,630	28 / 27
2026-08-10	$9.11	$18,136,435,272	16 / 21
2026-08-12	$9.11	$18,136,435,272	16 / 21
2026-08-13	$9.11	$18,136,435,272	16 / 21
2026-08-14	$9.11	$18,136,435,272	16 / 21
2026-08-15	$9.11	$18,136,435,272	16 / 21
2026-08-16	$9.11	$18,136,435,272	16 / 21
2026-08-17	$9.11	$18,136,435,272	16 / 21
2026-08-18	$9.11	$18,136,435,272	16 / 21
2026-08-19	$9.11	$18,136,435,272	16 / 21
2026-08-20	$9.17	$18,175,120,765	16 / 21
2026-08-21	$9.17	$18,175,120,765	16 / 21
2026-08-22	$9.17	$18,175,120,765	16 / 21
2026-08-23	$9.17	$18,175,120,765	16 / 21
2026-08-24	$9.17	$18,175,120,765	16 / 21
2026-08-25	$9.17	$18,175,120,765	16 / 21
2026-08-26	$9.17	$18,175,120,765	16 / 21
2026-08-27	$9.17	$18,175,120,765	16 / 21
2026-08-28	$9.17	$18,175,120,765	16 / 21
2026-08-29	$9.12	$18,137,663,983	16 / 21
2026-08-30	$9.12	$18,137,663,983	16 / 21
2026-08-31	$9.12	$18,137,663,983	16 / 21
2026-09-01	$9.12	$18,137,663,983	16 / 21
2026-09-02	$9.12	$18,137,663,983	16 / 21
2026-09-03	$9.12	$18,137,663,983	16 / 20
2026-09-04	$9.12	$18,137,664,357	16 / 21
2026-09-05	$9.14	$18,167,009,755	16 / 21
2026-09-06	$9.14	$18,167,009,755	16 / 21
2026-09-07	$9.14	$18,167,009,755	16 / 21
2026-09-08	$9.14	$18,167,009,755	16 / 21
2026-09-09	$9.14	$18,167,009,755	16 / 21
2026-09-10	$9.14	$18,167,009,755	16 / 21
2026-09-11	$9.14	$18,166,995,805	16 / 21
2026-09-12	$9.14	$18,166,995,805	16 / 21
2026-09-13	$9.14	$18,166,995,805	16 / 21
2026-09-14	$9.14	$18,166,995,805	16 / 21
2026-09-15	$9.14	$18,166,995,805	16 / 21
2026-09-16	$9.15	$18,170,352,948	16 / 21
2026-09-17	$9.15	$18,170,352,948	16 / 21
2026-09-18	$9.15	$18,170,352,948	16 / 21
2026-09-19	$9.15	$18,170,352,948	16 / 21
2026-09-20	$9.15	$18,170,352,948	16 / 21
2026-09-21	$9.15	$18,170,352,948	16 / 21
2026-09-22	$9.15	$18,170,366,898	16 / 21
2026-09-23	$9.15	$18,170,366,898	16 / 21
2026-09-24	$9.15	$18,170,366,898	16 / 21
2026-09-25	$9.15	$18,170,366,898	16 / 21
2026-09-26	$9.19	$18,226,133,880	16 / 22
2026-09-27	$9.19	$18,226,133,880	16 / 22
2026-09-28	$9.19	$18,226,133,880	16 / 22
2026-09-29	$9.19	$18,226,133,880	16 / 22
2026-09-30	$9.19	$18,226,133,880	16 / 22
2026-10-01	$9.20	$18,267,508,725	16 / 22
2026-10-02	$9.20	$18,267,508,725	16 / 22
2026-10-03	$9.20	$18,267,522,194	16 / 22
2026-10-04	$9.20	$18,267,522,601	16 / 22
2026-10-05	$9.20	$18,236,038,514	17 / 22
2026-10-06	$9.20	$18,236,038,514	17 / 22
2026-10-07	$9.20	$18,236,038,514	17 / 23
2026-10-08	$9.21	$18,250,838,514	17 / 23
2026-10-09	$9.18	$18,231,598,540	17 / 23
2026-10-10	$9.18	$18,231,598,540	17 / 23
2026-10-11	$9.18	$18,231,598,540	17 / 23
2026-10-12	$9.18	$18,231,598,540	17 / 23
2026-10-13	$9.18	$18,231,598,540	17 / 23
2026-10-14	$9.18	$18,230,165,840	16 / 23
2026-10-15	$9.18	$18,216,536,808	16 / 22

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	25	3	1
2026-06-01	23	4	1
2026-07-01	24	4	1
2026-08-01	24	4	0
2026-09-01	25	4	0
2026-10-01	26	4	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 26 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Sep 16–Oct 15 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

BMO CapitalOct 4

$329.00New observation · no comparable prior

Wells FargoSep 24

$340.00New observation · no comparable prior

$0$187.00$374.00

0 raises · 0 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Deliver diluted EPS of $5.60 to $5.70 in 2026Published status: Broken
Achieve revenue of $13.5 to $14 billion in 2026Published status: Broken

Next proof point

Oct 28, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.7%Typical daily move · historical

Downside history

-42.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Vertiv outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on revenue and earnings growth. However, the current thesis is challenged by volatile management and a high-risk environment.

What's priced into Vertiv

The market appears to have priced in a premium valuation compared to peers, indicating high expectations for future performance. There is an expectations gap that suggests the stock may be seen as justified despite its expensive nature.

What the fundamentals likely do

Management is on track with strong revenue and earnings per share growth, but capacity expansion and strategic acquisitions show mixed results. The near-term risk of missing earnings is relatively low, but the industry has seen peers miss expectations recently.

What Vertiv hinges on

The thesis hinges on whether VRT can maintain its growth trajectory and if sector bellwethers continue to perform well. Any cuts to guidance or negative trends in the broader industrial sector could significantly impact VRT's outlook.